By: Alanna Shaikh
This is not a scientifically sound list. It is not based on any kind of criteria that make sense. It’s just my list, of what I remember as the most interesting developments in 2010 that related to neglected tropical diseases.
1. The WHO issued its first annual report on neglected tropical diseases (NTDs). I was honestly surprised to discover it was the first, but better 2010 than never, right? This kind of formal recognition of the seriousness of NTDs is a big part of what will make them less neglected. The report itself was thorough and detailed, and called for all the right things – more research, better drug access, and support to build health systems to eliminate the NTDs.
2. Increased private participation in global health in general, and NTDs in particular. It seemed like the private sector was everywhere this year. We saw large drug donations to treat NTDs, including a five-year commitment from Glaxo Smith Kline to provide albendazole to protect children at risk for intestinal worms and a Sanofi Adventis cash commitment of $25 million dollars. We also saw broader corporate commitment to global health in companies that ranged from Coca-Cola to venture capital efforts.